Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

NCT02510118 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: mFOLFOX6
DRUG: XELOX
DRUG: Placebo ChangTai Keli
DRUG: ChangTai Keli

Sponsor

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Collaborators

[object Object]